Tci Wealth Advisors, Inc. Innoviva, Inc. Transaction History

Tci Wealth Advisors, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	BUY	$11.8 - $13.78 $4,236 - $4,947	359 Added 132.47%	630 $8,000
Q3 2022 Nov 08, 2022	SELL	$11.61 - $15.22 $23 - $30	-2 Reduced 0.73%	271 $3,000
Q3 2021 Oct 29, 2021	BUY	$13.06 - $17.24 $457 - $603	35 Added 14.71%	273 $5,000
Q2 2021 Aug 02, 2021	BUY	$11.45 - $13.96 $2,725 - $3,322	238 New	238 $3,000
Q3 2019 Oct 17, 2019	SELL	$10.05 - $14.55 $512 - $742	-51 Closed	0 $0
Q2 2019 Jul 23, 2019	SELL	$13.1 - $14.95 $694 - $792	-53 Reduced 50.96%	51 $1,000
Q1 2018 Apr 30, 2018	BUY	$13.8 - $16.99 $731 - $900	53 Added 103.92%	104 $2,000
Q2 2017 Aug 10, 2017	BUY	N/A	51	51 $1,000

228

79.1M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.